Alexis Jaramillo Cartagena, PhD, D(ABMM)
banner
alexclinmicro.bsky.social
Alexis Jaramillo Cartagena, PhD, D(ABMM)
@alexclinmicro.bsky.social
🔬 Assistant Prof, Pathology ‪@Duke | Director, Clin Micro Lab
🧫 Former Clin Micro Fellow ‪@Memorial Sloan Kettering
👩🏻‍🔬 Former Postdoc @broadinstitute.org
🎓 PhD @The Rockefeller University
Focus: Diagnostics, AMR, Structural Biology
Pinned
I’m excited to share that I’ve started a new chapter as Assistant Professor & Clinical Microbiology Section Director at @dukemedschool.bsky.social 🏥🔬.

This is a dream opportunity, and I’m so grateful 🙏. Looking forward to growing, learning, and advancing clinical microbiology & patient care 🚀💙.
Preparing for the ABMM was humbling—I left the exam feeling defeated 😔. Today, seeing the certificate with my name reminds me it’s real 🤏🙌. Grateful, humbled, and excited to keep learning and serving in this field 💡🧫✨.
September 30, 2025 at 8:42 PM
On #WorldSepsisDay, huge thanks to all the clinicians, nurses, lab professionals & researchers working to detect, treat & prevent #Sepsis. Your advances in diagnostics & therapies save lives every day. 💙 #PatientSafety #GlobalHealth #Infection #CriticalCare #MedTwitter
who.int WHO @who.int · Sep 13
It’s World #Sepsis Day
Sepsis kills 11 million people each year.

Symptoms incl.:
🔸Fever or shivering
🔸Confusion
🔸Shortness of breath
🔸Rash that does not fade when pressed
🔸Extreme discomfort
🔸Sweaty skin

Seek medical care as soon as possible when an infection is not getting better.
September 13, 2025 at 2:21 PM
Truly a rewarding journey — honored to be part of it! Huge thanks to @roby-b.bsky.social for your dedication and invaluable mentorship throughout. Your guidance made all the difference for everyone involved. Learned so much through this process 🙏
Good start to my workday! >1.5 yrs in review. Most I've ever learned / changed how I've thought about a project from the time we started writing, through the review process, to acceptance. (All trackable via bioRxiv versions!) Thread at some point?
September 11, 2025 at 1:18 PM
Game-changing #TIL therapy advance! 🚀 Dr. Beth Shaz’s new protocol cuts production to 4 wks using T-cell media + AB serum + α-CD3/CD28 nanobeads (no feeder cells). Faster, efficient, scalable—opening doors for more patients. #CancerImmunotherapy
Dr. Beth Shaz’s Study Aims to Streamline Production of Promising Cancer Therapy
Professor Beth Shaz, MD, MBA, helped lead a study to advance efforts to make tumor-infiltrating lymphocyte (TIL) therapy more accessible to cancer patients. TIL therapy, which uses a patient’s own imm...
pathology.duke.edu
September 8, 2025 at 1:45 PM
I loved the ~10ish years I lived in the UES, but this is out of control 😱😱😱
Upper East Side: A Horror Story in One Image
September 4, 2025 at 8:13 PM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
In a randomized, controlled trial, persons with early syphilis received a single treatment or three treatments with benzathine penicillin G at a dose of 2.4 million units. No benefit was seen with the additional doses. Full trial results: nej.md/3UVCKVZ

#MedSky #IDSky
September 3, 2025 at 9:10 PM
✨ Excited to dive into tomorrow’s seminar on molecular epidemiology by Robert Potter @plasmidsaurus.bsky.social @childrensphila.bsky.social 🔬🧬
Looking forward to learning a ton from this terrific session! 🚀📚 #ClinicalMicrobiology www.chop.edu/doctors/pott...
September 4, 2025 at 2:45 PM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
📣Annual Book Development Prize Competition 📣
Submissions are now invited for the 2026 Award, which funds authors to turn a proposal into a book in the Social Histories of Medicine series, published by @manchesterup.bsky.social Applications are accepted on a rolling basis until 16 Jan 2026.
#histmed
Annual Book Development Prize Competition
Rules and Entry Form The Society for the Social History of Medicine (SSHM) invites submissions to its Annual Book Development Award Competition. The Award Two awards of £2000.00 each will be given …
sshm.org
August 20, 2025 at 3:17 PM
This is amazing Sarah @microbecharmer.bsky.social !! I love how each cell in the fusarium macroconidia has its own personality!!!
Time for some fungi: Fusarium macroconidiae, Cunninghamella, and Paracoccidioides!
#IDsky #ClinicalMicrobiology #MedicalMicrobiology #mycology

Find them here: www.etsy.com/shop/Microbe...
September 4, 2025 at 12:15 PM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
Do you have a period?
Do you live in the continental US?
Then do I have a study for you - please join VAMPP and help expand our understanding of the vaginal microbiome!
Scan the QR code on the bottom left to see if you're eligible and learn more
January 22, 2025 at 1:22 AM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
September 1, 2025 at 5:35 AM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
🎓 Applications for Institut Pasteur's PhD programs open Sept 1-Oct 20, 2025 for October 2026 entry.

Apply to up to 4 projects across 6 programs: PPU, PPU-IMAGINE @institutimagine.bsky.social, PPU-@ox.ac.uk, PPU-EID @upcite.bsky.social & more 🧬

Register now ✍️ www.pasteur.fr/en/education...
September 1, 2025 at 9:44 AM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
New #ISEPpapers! Regulated development of cannibalistic supergiant cells www.biorxiv.org/content/10.1...

"we describe a ciliate undergoing drastic morphological transformations... supergiants increase in size, change shape, and modify behaviour to cannibalize clonal relatives"

#protists #microbes
August 30, 2025 at 11:41 AM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
We are hiring! Please circulate in your networks. Join us in beautiful warm and wonderful KZN to answer some important questions about asymptomatic / subclinical TB.

#TBsky #IDsky 🧪
📢 AHRI is #hiring for 2️⃣ key roles for an exciting new study on asymptomatic TB transmission.

Successful candidates will join the leadership of the study, working closely with our director for clinical trials Limakatso Lebina & @emilybethwong.bsky.social

More ➡️ ahri.wd3.myworkdayjobs.com/AHRI1
August 21, 2025 at 3:25 PM
Reposted by Alexis Jaramillo Cartagena, PhD, D(ABMM)
The 2024 rankings of bacterial threats
August 27, 2025 at 4:19 PM
One of my favorite organism!
SIF
A review focuses on Alternaria alternata: the most common pathogen on date palm.
Details: https://maxapress.com/article/doi/10.48130/sif-0024-0012
August 31, 2025 at 6:01 PM
I’m excited to share that I’ve started a new chapter as Assistant Professor & Clinical Microbiology Section Director at @dukemedschool.bsky.social 🏥🔬.

This is a dream opportunity, and I’m so grateful 🙏. Looking forward to growing, learning, and advancing clinical microbiology & patient care 🚀💙.
August 31, 2025 at 3:22 PM
Thrilled to wrap up my Clinical Microbiology Fellowship at MSK! 🧫💉 Huge thanks to @ebabady.bsky.social & the incredible
@mskcancercenter.bsky.social team for mentorship, guidance, and teaching 🙏✨ Grateful for the chance to support infection diagnosis in critically ill patients—what an experience!🌟🩺
August 31, 2025 at 12:56 AM
Sepsis kills fast — we fast diagnostics

This pilot study from @broadinstitute.org @mgh-id.bsky.social by David Roach, Noam Shoresh, @roby-b.bsky.social + team used CRISPR-Cas13a to detect gram-negatives and resistance markers from ~200 real clinical blood cultures. www.medrxiv.org/content/10.1...
August 31, 2025 at 12:00 AM